Clinical Trial Update: CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update examines using CD34+ malignant stem cell selection for patients receiving allogeneic stem cell transplants in Phase 1/Phase 2. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Hodgkin Lymphoma
• Juvenile Myelomonocytic Leukemia
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Snippet

Sponsor: Diane George | Conditions: Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING